Posted on May 2, 2015 by Sitemaster
According to a newly published paper in the journal Pain, the presence of a particular genetic marker in cancer cells may be a key factor in risk for cancer-related pain. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gene, pain, TMPRSS2 | Leave a comment »
Posted on November 10, 2009 by Sitemaster
In the continuing search for tests that will do a better job than the PSA test of defining clinically significant prostate cancer (as opposed to indolent disease) while it is still in its earliest possible stages, two new papers have provided information based on laboratory (not clinical studies). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: catenin, claudin, Diagnosis, ERG, risk, TMPRSS2 | 2 Comments »
Posted on August 11, 2009 by Sitemaster
Today’s news items deal with:
- The effect of dutasteride on the results of PCA3 tests
- How common is the TMPRSS2 fusion gene in men with prostate cancer in North America?
- Can prostate biopsy data predict laterality of prostate cancer with accuracy? … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: biopsy, dutasteride, ERG, laterality, PCA3, TMPRSS2 | 7 Comments »